Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Paliperidone LAI Resolves Hypersexuality in Veteran With Schizophrenia

Paliperidone LAI Resolves Hypersexuality in Veteran With Schizophrenia

November 19, 2026 Health Desk Health

A 73-year-old veteran with schizophrenia stopped exhibiting inappropriate sexual behaviors after his care team switched him to paliperidone long-acting injectable, a case report that Medscape covered this week, the report states.

His auditory hallucinations and hypersexual behavior resolved after six months on the injectable antipsychotic combined with individual psychotherapy.

  • A case report describes a 73-year-old man with schizophrenia whose hypersexual behavior and hallucinations resolved after switching to paliperidone long-acting injectable.
  • The patient had not improved on lurasidone plus sertraline; the change followed an incident of sexual misconduct, Medscape reported.
  • Researchers caution the finding comes from a single patient and that ongoing monitoring and individualized treatment remain essential.

Problematic hypersexual behavior in patients with schizophrenia carries real clinical weight: it can lead to misconduct incidents, disrupted care, and worsening psychosocial functioning. There is no established standard of care for hypersexuality comorbid with psychotic illness, which is why a documented treatment response — even in one patient — draws clinical attention, Medscape reported.

Paliperidone is a second-generation antipsychotic already approved for schizophrenia and schizoaffective disorder. It works through antagonism of dopamine D2 and serotonin 2A receptors. Because those same neurochemical pathways are involved in impulse control, clinicians have taken interest in whether the drug could help manage impulsive and problematic sexual behaviors, according to the case report.

The patient, a 73-year-old male veteran with long-standing schizophrenia, hyperreligiosity, and hypersexuality, continued to experience auditory hallucinations and to exhibit inappropriate sexual behaviors despite treatment with lurasidone and sertraline, the report states. After an incident of sexual misconduct, his care team transitioned him to oral risperidone and then to paliperidone long-acting injectable.

Following initiation of the injectable, the patient’s mood improved. His auditory hallucinations, alcohol consumption, and hypersexual behavior all decreased, and his renal and hepatic function remained stable throughout, according to the case report.

After six months of individual psychotherapy while receiving paliperidone LAI, his auditory hallucinations and hypersexual behavior resolved, and his psychosocial functioning improved, Medscape reported.

The report’s conclusion is deliberately narrow. It illustrates the complexity of treating schizophrenia with comorbid hypersexual behavior and suggests that long-acting injectable antipsychotics such as paliperidone may benefit these patients, the authors state. A single case cannot establish efficacy; there was no control group, no blinding, and the concurrent psychotherapy makes it impossible to separate the injectable’s contribution from the therapy’s.

The authors emphasize that ongoing monitoring and individualized treatment remain essential, according to the report. Long-acting injectable antipsychotics carry their own considerations — injection-site reactions, dose adjustments in renal impairment, and the standard contraindication profile of D2 antagonists — so any off-label use would require individualized risk assessment by the treating psychiatrist.

For clinicians, the practical signal is procedural rather than pharmacological: when a patient with schizophrenia shows persistent hypersexual behavior despite adequate trials of first-line agents, a reassessment of the regimen — including long-acting injectable options — is a documented path worth discussing. Patients and families facing similar situations would typically raise the question with a psychiatrist experienced in antipsychotic switching and LAI initiation.

The case also highlights the role of structured psychotherapy alongside medication changes; in this patient, resolution came after six months of combined treatment, not from the injection alone, the report indicates.


Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • Harvard Lists Fruits That Help Manage Blood Sugar After 50
  • Scientists and Philanthropies Scramble to Fill Gaps After Federal Science Cuts
  • California Announces New Homekey+ Projects and Funding to Address Homelessness and Veteran Housing (newsdirectory3.com)

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service